Trials of transvaginal mesh devices for pelvic organ prolapse: a systematic database review of the US FDA approval process.
PMID : 29212782 ·
C, a, r, l, , J, , H, e, n, e, g, h, a, n, ;, , B, e, n, , G, o, l, d, a, c, r, e, ;, , I, g, h, o, , O, n, a, k, p, o, y, a, ;, , J, e, f, f, r, e, y, , K, , A, r, o, n, s, o, n, ;, , T, o, m, , J, e, f, f, e, r, s, o, n, ;, , A, n, n, e, t, t, e, , P, l, u, d, d, e, m, a, n, n, ;, , K, a, m, a, l, , R, , M, a, h, t, a, n, i
Publicité
Résumé
Transvaginal mesh devices are approved in the USA by the Food and Drug Administration (FDA), through the 510(k) system. However, there is uncertainty about the benefit to harm balance of mesh approved for pelvic organ prolapse. We, therefore, assessed the evidence at the time of approval for transvaginal mesh products and the impact of safety studies the FDA mandated in 2012 because of emerging harms. We used FDA databases to determine the evidence for approval of transvaginal mesh. To create a
Publicité
Source officielle
Voir sur PubMed →Données issues de PubMed / NCBI. Pour le texte intégral et les informations les plus récentes, consultez toujours la notice officielle.